This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

ELI-002 7P showed robust mKRAS-specific T-cell responses in 99% of evaluable pancreatic cancer patients in the phase 2 trial. The vaccine targets seven common KRAS mutations, prevalent in a ...

Please provide your email address to receive an email when new articles are posted on . All patients who received a personalized vaccine for advanced kidney cancer achieved an immune response. All ...

Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more ...

Glioblastoma vaccine shows promise by activating immune response and improving survival in a phase 1 trial at Siteman Cancer Center.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake ...

The novel oral polio vaccine type 2 (nOPV2) induced intestinal mucosal immune responses comparable to those induced by the traditional Sabin monovalent oral polio vaccine type 2 (mOPV2) across ...

A shot of a shingles vaccine blocks reactivation, potentially preventing the virus from triggering brain inflammation that ...

Findings showed Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines. Topline data were announced from a phase 3 trial evaluating Merck’s 21-valent ...

A pharmacist holds a Pfizer and BioNTech COVID-19 vaccine shot on Thursday, April 24, 2025, in Portland, Ore. University of Florida researchers found that advanced lung and skin cancer patients lived ...